4//SEC Filing
Sagent Pharmaceuticals, Inc. 4
Accession 0001562180-16-001772
CIK 0001369786operating
Filed
Feb 22, 7:00 PM ET
Accepted
Feb 23, 5:55 PM ET
Size
13.7 KB
Accession
0001562180-16-001772
Insider Transaction Report
Form 4
Behrens Mary Taylor
Director
Transactions
- Exercise/Conversion
Common Stock
2016-02-22+567→ 6,407 total - Exercise/Conversion
Restricted Stock Units
2016-02-21−760→ 760 total→ Common Stock (760 underlying) - Award
Restricted Stock Units
2016-02-22+8,556→ 8,556 total→ Common Stock (8,556 underlying) - Exercise/Conversion
Restricted Stock Units
2016-02-22−567→ 0 total→ Common Stock (567 underlying) - Exercise/Conversion
Common Stock
2016-02-21+760→ 5,840 total
Footnotes (5)
- [F1]Vesting of restricted stock units.
- [F2]Each restricted stock unit represents a contingent right to receive one share of SGNT common stock.
- [F3]The restricted stock units vest in four equal annual installments beginning on February 21, 2014. Vested shares will generally be delivered to the reporting person within 30 days following the vesting date.
- [F4]The restricted stock units vest in four equal annual installments beginning on February 22, 2013. Vested shares will generally be delivered to the reporting person within 30 days following the vesting date.
- [F5]The restricted stock units vest in four equal annual installments beginning on February 22, 2017. Vested shares will generally be delivered to the reporting person within 30 days following the vesting date.
Documents
Issuer
Sagent Pharmaceuticals, Inc.
CIK 0001369786
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001369786
Filing Metadata
- Form type
- 4
- Filed
- Feb 22, 7:00 PM ET
- Accepted
- Feb 23, 5:55 PM ET
- Size
- 13.7 KB